Influence of reduction of standard preoperative fasting time and that added with protein in patients with head and neck cancer
- Conditions
- Postoperative complicationsInsulin resistanceMalignant neoplasm of head, face and neckHead and Neck Neoplasms.C76.0C18.452.394.968.500C23.550.767C04.588.443
- Registration Number
- RBR-63ctjw
- Lead Sponsor
- Instituto Nacional de Câncer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
All patients who are candidates for elective surgeries; who are 19 years of age or older; and consent to participate in the study through the signing of the Informed Consent Form.
Volunteers inability to receive oral feeding in the preoperative period; without adherence to any of the phases of the study protocol; in use of prophylactic antiemetics 24 hours before surgery and in the immediate postoperative period; with previous diagnosis of diabetes mellitus, chronic kidney disease and / or liver disease, obesity (WHO, 2000); with presence of gastroesophageal reflux; intestinal obstruction and cases of gastroparesis and / or pyloric stenosis and surgeries with low nutritional impact (base of skull, maxillary sinuses, thyroid gland, parotid glands, cutaneous and ocular).
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increased muscle strength in the group receiving CHO-P, compared to the CHO group, around 10% higher, verified by assessment of palmar grip strength.
- Secondary Outcome Measures
Name Time Method Expected outcome 1: Reduction in response to insulin resistance, measured by the HOMA-IR and QUICKI indices, more effective in the CHO-P group with a difference of p <0.05 in relation to the CHO group.<br><br>Expected outcome 2: Lower incidence of postoperative complications, assessed by self-collected data sheet, in the CHO-P group compared to the CHO group. There is no expected reduction parameter.